TABLE 4.
Summary of PCR experimentsa
| ECOR strain no. | PCR result with the indicated primer pairb
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| int1.F-int1.R | sul.F-sul.R | qac.F-qac.R | merA1–merA5 | merR1–merT1 | int1.R-qac.F | int1.R-aadA.R | IRT-merA1 | IRI-int1.F | merT1–38/- | |
| 3 | + | + | + | + | + | + | + | + | + | + |
| 4 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 6 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 10 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 16 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 17 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 18 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 19 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 24 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 25 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 30 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 31 | + | + | + | + | + | + | − | − | + | + |
| 37 | + | + | + | + | + | + | + | + | + | + |
| 38 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 39 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 48 | + | + | + | + | + | + | + | + | + | + |
| 54 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
| 70 | − | − | − | ND | ND | ND | ND | ND | ND | ND |
PCR regimens and antimicrobial agents tested are listed in Materials and Methods.
+, PCR amplification product; −, no amplification product; ND, not determined.